Raghuram Selvaraju HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
223
Avg Return
Past Year
Past Year
26%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
95.2%
Neutral
4.3%
Negative
0.4%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Staples
Financials
Healthcare
Materials
Consumer Staples
Packaged Foods
Financials
Asset Management
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Instruments & Supplies
Materials
Specialty Chemicals
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Reiterated
| $40 |
72%
upside
| 2 | +65% |
0
%
| 22 May ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $20 |
95%
upside
| 4 | -3.6% |
0
%
| 20 May ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $11 |
138%
upside
| 1 | +88% |
0
%
| 14 Apr ‘25 9 months ago |
|
|
|
Buy
Reiterated
| $10 |
1,526%
upside
| 2 | -24% |
0
%
| 21 Mar ‘25 9 months ago |
|
|
|
Buy
Reiterated
| $10 |
510%
upside
| 1 | -14% |
0
%
| 18 Mar ‘25 9 months ago |
|
|
|
Buy
Maintained
| $34 |
126%
upside
| 1 | +125% |
0
%
| 17 Mar ‘25 9 months ago |
|
|
|
Buy
Reiterated
| $10 |
23%
upside
| 2 | +249% |
0
%
| 14 Mar ‘25 10 months ago |
|
|
|
Buy
Reiterated
| $80 |
147%
upside
| 1 | +257% |
0
%
| 10 Mar ‘25 10 months ago |
|
|
|
Buy
Reiterated
| $20 |
313%
upside
| 2 | +4.7% |
0
%
| 6 Mar ‘25 10 months ago |
|
|
|
Buy
Reiterated
| $9 |
552%
upside
| 1 | -16% |
0
%
| 7 Feb ‘25 11 months ago |
|
|
|
Buy
Reiterated
| $5 |
95%
upside
| 1 | +198% |
0
%
| 30 Jan ‘25 11 months ago |
|
|
|
Buy
Reiterated
| $4 |
267%
upside
| 1 | -20% |
0
%
| 23 Jan ‘25 11 months ago |
|